M2782335
Goserelin , 98% , 65807-02-5
Synonym(s):
[D-Ser(tBu)6,Azagly10]-LHRH acetate salt;Goserelin acetate
CAS NO.:65807-02-5
Empirical Formula: C59H84N18O14
Molecular Weight: 1269.41
MDL number: MFCD01747329
Pack Size | Price | Stock | Quantity |
10mg | RMB1121.60 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Density | 1.50±0.1 g/cm3(Predicted) |
storage temp. | −20°C |
solubility | H2O: 20 mg/mL, clear, colorless |
form | white powder |
pka | 9.82±0.15(Predicted) |
InChIKey | BLCLNMBMMGCOAS-URPVMXJPSA-N |
Description and Uses
Goserelin is an analog of luteinizing hormone-releasing hormone (LHRH) useful in the treatment of malignancies responsive to hormonal manipulation. Administered parenterally in a biodegradable depot, goserelin is reportedly as effective as orchidectomy and oophorectomy in patients with advanced prostate carcinoma and pre-menopausal breast cancer.
Labeled Goserelin, intended for use as an internal standard for the quantification of Goserelin by GC- or LC-mass spectrometry.
Safety
Symbol(GHS) | GHS07,GHS08 |
Signal word | Danger |
Hazard statements | H334-H332-H317 |
Precautionary statements | P261-P272-P280-P302+P352-P333+P313-P321-P363-P501-P261-P285-P304+P341-P342+P311-P501-P261-P271-P304+P340-P312 |
Safety Statements | 22-24/25 |
WGK Germany | 3 |
HS Code | 3504009000 |